BlueLinx Holdings diskutieren
BlueLinx Holdings
WKN: A2ALQ5 / Symbol: BXC / Name: BlueLinx Holdings / Aktie / Papier & Holz / Small Cap /
91,50 €
-2,14 %
BlueLinx Holdings Inc. (NYSE: BXC) had its price target raised by analysts at Benchmark Co. from $100.00 to $144.00. They now have a "buy" rating on the stock.
Ratings data for BXC provided by MarketBeat
BlueLinx Holdings Inc. (NYSE: BXC) had its price target lowered by analysts at Benchmark Co. from $144.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for BXC provided by MarketBeat
BlueLinx Holdings Inc. (NYSE: BXC) had its price target lowered by analysts at Craig Hallum from $130.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for BXC provided by MarketBeat
BlueLinx Holdings Inc. (NYSE: BXC) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $135.00 price target on the stock.
Ratings data for BXC provided by MarketBeat
BlueLinx Holdings Inc. (NYSE: BXC) had its price target raised by analysts at DA Davidson from $121.00 to $137.00. They now have a "buy" rating on the stock.
Ratings data for BXC provided by MarketBeat
BlueLinx Holdings Inc. (NYSE: BXC) had its price target raised by analysts at Craig Hallum from $125.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for BXC provided by MarketBeat
Neueste Beiträge
StockNews_com in Ampio Pharmaceuticals Inc. diskutieren